Blood test may end guesswork in psoriasis dosing

NCT ID NCT06398106

Recruiting now Disease control Sponsor: University Hospital, Ghent Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether measuring biologic drug levels in the blood can help doctors adjust doses for people with psoriasis. About 210 adults on certain biologics will either get dose advice based on blood tests or continue standard care. The goal is to maintain disease control while reducing side effects and costs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS VULGARIS

Contacts and locations

Locations

AZ Alma
RECRUITING

Eeklo, 9900, Belgium
AZ Maria Middelares
RECRUITING

Ghent, Belgium
AZ Sint-Jan
RECRUITING

Bruges, Belgium
CHU Liège
ACTIVE_NOT_RECRUITING

Liège, Belgium
CHU Saint-Pierre
RECRUITING

Brussels, 1000, Belgium
Clinique André Renard
WITHDRAWN

Herstal, Belgium
Dermatologie Handelskaai
RECRUITING

Kortrijk, Belgium
Dermatologie Maldegem
RECRUITING

Maldegem, Belgium
Dermatologiepraktijk huidziekten Geel
RECRUITING

Geel, Belgium
Grand Hôpital de Charleroi
ACTIVE_NOT_RECRUITING

Charleroi, Belgium
UCL Saint-Luc
ACTIVE_NOT_RECRUITING

Brussels, Belgium
ULB Erasme
NOT_YET_RECRUITING

Brussels, Belgium
UZ Brussel
RECRUITING

Brussels, Belgium
UZ Gent
RECRUITING

Ghent, Belgium
UZ Leuven
RECRUITING

Leuven, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.